FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to peptide derivatives of general formula
,
their stereoisomers, mixtures and/or pharmaceutically acceptable salts, to methods for preparing them, to pharmaceutical compositions containing them, to using them for treating, preventing and/or diagnosing conditions, disorders and/or pathologies involving sstr1, sstr2, sstr3, sstr4 and/or sstr5 somatostatin receptor expression.
EFFECT: preparing the compositions for preventing and/or diagnosing the conditions, disorders and/or pathologies involving sstr1, sstr2, sstr3, sstr4 and/or sstr5 somatostatin receptor expression.
14 cl, 5 tbl, 33 ex
Title | Year | Author | Number |
---|---|---|---|
CORTISTATIN ANALOGUES FOR TREATMENT OF INFLAMMATORY AND / OR IMMUNOPATHOLOGICAL DISEASES | 2014 |
|
RU2678315C2 |
GLYCOSYLATED POLYPEPTIDES AND MEDICINAL COMPOSITIONS CONTAINING THESE POLYPEPTIDES | 2012 |
|
RU2624034C2 |
GLYCOSYLATED POLYPEPTIDES AND MEDICINAL COMPOSITIONS CONTAINING THESE POLYPEPTIDES | 2012 |
|
RU2627184C2 |
METHOD FOR MODULATING CELL PROLIFERATION OF MEDULLARY THYROID CARCINOMA | 2002 |
|
RU2275934C2 |
COMBINATION OF SOMATOSTATIN ANALOGUES WITH VARIED SELECTIVITY WITH REGARD TO HUMAN SOMATOSTATIN RECEPTORS SUBTYPES | 2007 |
|
RU2451520C2 |
METHOD FOR MODULATING CELL PROLIFERATION OF THYROID MEDULLARY CARCINOMA | 2005 |
|
RU2317824C2 |
METHOD OF MODULATION OF PROLIFERATION OF CELLS OF THYROID GLAND MEDULLARY CARCINOMA | 2002 |
|
RU2352578C2 |
SOMATOSTATIN ANTAGONISTS | 2002 |
|
RU2328504C2 |
USING SOMATOSTATIN ANALOGUES IN MENINGIOMA | 2008 |
|
RU2523416C2 |
SOMATOSTATIN ANTAGONISTS | 2002 |
|
RU2263678C2 |
Authors
Dates
2014-08-20—Published
2010-05-06—Filed